Lapitahe, Jeralyn M.
HRN: 24-63-42 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2024
CEFUROXIME 500MG (TAB)
03/13/2024
03/20/2024
PO
500mg
BID
S/P RMLE
Checking Final Appropriateness